Contineum Therapeutics, Inc. (CTNM) Operating income 2023–2025
Contineum Therapeutics, Inc. (CTNM) annual operating income history from SEC filings — each fiscal year as reported.
-$68.1MFY2025 · since FY2023: $16.1M → -$68.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$68.1M | -33.7% |
| FY2024 | -$50.9M | -416.6% |
| FY2023 | $16.1M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More CTNM financial trends
CTNM RevenueCTNM Net incomeCTNM Net marginCTNM Gross profitCTNM Gross marginCTNM Operating marginCTNM Operating cash flowCTNM Free cash flowCTNM Capital expendituresCTNM Return on equityCTNM Stock buybacksCTNM Dividends paidCTNM Total assetsCTNM Total liabilitiesCTNM Shareholders’ equityCTNM overview →